FDA Says Zantac Should Be Pulled From Market, Citing Cancer Risk

  • 📰 NPR
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

The FDA has ordered manufacturers to immediately pull all prescription and over-the-counter versions of the heartburn medication Zantac, citing concern that a contaminant poses a cancer risk.

, explained in a statement Wednesday."However, since we don't know how or for how long the product might have been stored, we decided that it should not be available to consumers and patients unless its quality can be assured.", a company that does safety testing on popular drugs, discovered the contaminant in alarming levels.

"Our tests in lab conditions seem to pretty clearly show that the drug is able to degrade into NDMA by itself, either in the tablet or actually in the human body," Valisure founder and CEO David Light recalled in a conversation with NPRThe FDA said Wednesday that it is sending letters to all ranitidine manufacturers recommending that they pull their products from the market.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 96. in MY
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Have you or a loved one taken medication like Zantac, and experienced abdominal pain or stomach or other cancers? You could be entitled to compensation. Call Utah's Robert DeBry and Associates right now at 801-699-9999 or online at zantac zantacrecall

They did that last year.

Oh, now EVIL $ FDA $ WANTS TO PULL POISON ZANTAC, MILLIONS HAVE CANCER NOW$$$$$$$$$$$$$$$$$

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines